Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Osteoporosis

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    October 2021

  1. Corrigendum to: Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Oct 26. pii: 6410701. doi: 10.1210.
    PubMed    


    September 2021
  2. FERRARI S
    Short or long-term osteoporosis therapy with denosumab ?
    J Clin Endocrinol Metab. 2021 Sep 25. pii: 6375342. doi: 10.1210.
    PubMed    


  3. SHIEH A, Ruppert KM, Greendale GA, Lian Y, et al
    Associations of age at menopause with postmenopausal bone mineral density and fracture risk in women.
    J Clin Endocrinol Metab. 2021 Sep 19. pii: 6372418. doi: 10.1210.
    PubMed     Abstract available


    August 2021
  4. VIOLA V, Tramontana F, Leanza G
    Letter to the Editor from Viola Viola: "Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis".
    J Clin Endocrinol Metab. 2021 Aug 14. pii: 6352412. doi: 10.1210.
    PubMed    


  5. KARAKILIC E, Saygili ES
    Letter to the Editor From Karakilic and Saygili:" Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes".
    J Clin Endocrinol Metab. 2021 Aug 13. pii: 6350455. doi: 10.1210.
    PubMed    


  6. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Response letter to the Editor from Dr. Viola et al. "Diminishing value from multiple serial bone densitometry in women receiving antiresorptive medication for osteoporosis."
    J Clin Endocrinol Metab. 2021 Aug 7. pii: 6345421. doi: 10.1210.
    PubMed    


  7. CROMER SJ, Yu EW
    Challenges and opportunities for osteoporosis care during the COVID-19 pandemic.
    J Clin Endocrinol Metab. 2021 Aug 3. pii: 6337853. doi: 10.1210.
    PubMed     Abstract available


    July 2021
  8. KU EJ, Yoo WS, Lee EK, Ahn HY, et al
    Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2021 Jul 24. pii: 6327817. doi: 10.1210.
    PubMed     Abstract available


  9. KUZMA M, Vanuga P, Sagova I, Pavai D, et al
    Vertebral fractures occur despite control of acromegaly and are predicted by cortical volumetric bone mineral density.
    J Clin Endocrinol Metab. 2021 Jul 16. pii: 6322668. doi: 10.1210.
    PubMed     Abstract available


  10. SCHMITZ D, Ek WE, Berggren E, Hoglund J, et al
    Genome-Wide Association Study of Estradiol Levels, and the Causal Effect of Estradiol on Bone Mineral Density.
    J Clin Endocrinol Metab. 2021 Jul 13. pii: 6320117. doi: 10.1210.
    PubMed     Abstract available


  11. WARD LM, Ma J, Robinson ME, Scharke M, et al
    Osteoporotic Fractures and Vertebral Body Reshaping in Children with Glucocorticoid-Treated Rheumatic Disorders.
    J Clin Endocrinol Metab. 2021 Jul 7. pii: 6316730. doi: 10.1210.
    PubMed     Abstract available


  12. WARD LM, Choudhury A, Alos N, Cabral DA, et al
    Zoledronic acid versus placebo in pediatric glucocorticoid-induced osteoporosis: A randomized double-blind phase 3 trial.
    J Clin Endocrinol Metab. 2021 Jul 6. pii: 6316209. doi: 10.1210.
    PubMed     Abstract available


  13. LING CW, Miao Z, Xiao ML, Zhou H, et al
    The Association of Gut Microbiota with Osteoporosis is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313243. doi: 10.1210.
    PubMed     Abstract available


  14. MITCHELL A, Fall T, Melhus H, Lind L, et al
    Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women.
    J Clin Endocrinol Metab. 2021 Jul 2. pii: 6313244. doi: 10.1210.
    PubMed     Abstract available


    June 2021
  15. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  16. YOKOMOTO-UMAKOSHI M, Umakoshi H, Iwahashi N, Matsuda Y, et al
    Protective Role of DHEAS in Age-related Changes in Bone Mass and Fracture Risk.
    J Clin Endocrinol Metab. 2021 Jun 22. pii: 6307743. doi: 10.1210.
    PubMed     Abstract available


  17. CHAPURLAT R
    Of the Futility of Repeating BMD Measurement in Treated Osteoporotic Women.
    J Clin Endocrinol Metab. 2021 Jun 17. pii: 6303538. doi: 10.1210.
    PubMed    


    May 2021
  18. KIM JA, Lee JS, Song E, Roh E, et al
    Association between Visit-to-Visit Fasting Plasma Glucose Variability and Osteoporotic Fractures in nondiabetic subjects.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6284334. doi: 10.1210.
    PubMed     Abstract available


  19. ZAWORSKI C, Cheah J, Koff MF, Breighner R, et al
    MRI-based texture analysis of trabecular bone for opportunistic screening of skeletal fragility.
    J Clin Endocrinol Metab. 2021 May 17. pii: 6276953. doi: 10.1210.
    PubMed     Abstract available


  20. MAKRAS P, Appelman-Dijkstra NM, Papapoulos SE, van Wissen S, et al
    The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.
    J Clin Endocrinol Metab. 2021 May 12. pii: 6274510. doi: 10.1210.
    PubMed     Abstract available


  21. ZHU J, Briganti EM
    Letter to the Editor from Jasmine Zhu: Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2021 May 6. pii: 6268612. doi: 10.1210.
    PubMed    



  22. Corrigendum to: "Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT".
    J Clin Endocrinol Metab. 2021 May 4. pii: 6263815. doi: 10.1210.
    PubMed    


    April 2021
  23. SHIEH A, Karlamangla AS, Huang MH, Han W, et al
    Faster lumbar spine bone loss in midlife predicts subsequent fracture independent of starting bone mineral density.
    J Clin Endocrinol Metab. 2021 Apr 27. pii: 6254916. doi: 10.1210.
    PubMed     Abstract available


  24. CIARDULLO S, Muraca E, Zerbini F, Manzoni G, et al
    NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population.
    J Clin Endocrinol Metab. 2021 Apr 20. pii: 6241840. doi: 10.1210.
    PubMed     Abstract available


    March 2021
  25. KLINE GA, Morin SN, Feldman S, Lix LM, et al
    Diminishing value from multiple serial bone densitometry in women receiving anti-resorptive medication for osteoporosis.
    J Clin Endocrinol Metab. 2021 Mar 30. pii: 6204740. doi: 10.1210.
    PubMed     Abstract available


  26. REEVES KW, Vieyra G, Grimes NP, Meliker J, et al
    Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6180137. doi: 10.1210.
    PubMed     Abstract available


  27. LANGDAHL BL, Hofbauer LC, Forfar JC
    Cardiovascular Safety and Sclerostin Inhibition - a mini-review.
    J Clin Endocrinol Metab. 2021 Mar 23. pii: 6182322. doi: 10.1210.
    PubMed     Abstract available


  28. XUE S, Zhang Y, Qiao W, Zhao Q, et al
    An Updated Reference for Calculating Bone Mineral Density T-Scores.
    J Clin Endocrinol Metab. 2021 Mar 18. pii: 6178347. doi: 10.1210.
    PubMed     Abstract available


  29. NG TANG FUI M, Hoermann R, Bracken K, Handelsman DJ, et al
    Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6162862. doi: 10.1210.
    PubMed     Abstract available


  30. GONG R, Xiao HM, Zhang YH, Zhao Q, et al
    Identification and Functional Characterization of Metabolites for Bone Mass in Peri-/Post-menopausal Chinese Women.
    J Clin Endocrinol Metab. 2021 Mar 8. pii: 6161511. doi: 10.1210.
    PubMed     Abstract available


    February 2021

  31. Corrigendum to: "Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health Initiative".
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146952. doi: 10.1210.
    PubMed    


  32. QU Z, Yang F, Yan Y, Hong J, et al
    Relationship between serum nutritional factors and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2021 Feb 13. pii: 6134779. doi: 10.1210.
    PubMed     Abstract available


  33. CIPRIANI C, Minisola S, Bilezikian JP, Diacinti D, et al
    Vertebral Fracture Assessment in postmenopausal women with post-surgical hypoparathyroidism.
    J Clin Endocrinol Metab. 2021 Feb 10. pii: 6132444. doi: 10.1210.
    PubMed     Abstract available


  34. VIGEVANO F, Gregori G, Colleluori G, Chen R, et al
    In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength, and Low Bone Turnover.
    J Clin Endocrinol Metab. 2021 Feb 4. pii: 6127536. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  35. KONG SH, Kim JH, Shin CS
    Serum Spermidine as a Novel Potential Predictor for Fragility Fractures.
    J Clin Endocrinol Metab. 2021;106:e582-e591.
    PubMed     Abstract available


  36. MISRA M, Bredella MA
    Bone Metabolism in Adolescents Undergoing Bariatric Surgery.
    J Clin Endocrinol Metab. 2021;106:326-336.
    PubMed     Abstract available


  37. DREYER P, Palomo T, Brandao CMA, Vieira JGH, et al
    Letter to the Editor from Dreyer, et al: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 22. pii: 6114543. doi: 10.1210.
    PubMed    


  38. YUAN S, Wan ZH, Cheng SL, Michaelsson K, et al
    Insulin-like Growth Factor-1, Bone Mineral Density, and Fracture: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2021 Jan 19. pii: 6104229. doi: 10.1210.
    PubMed     Abstract available



  39. Corrigendum to: "Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF".
    J Clin Endocrinol Metab. 2021 Jan 13. pii: 6094895. doi: 10.1210.
    PubMed    


  40. HANNEMANN A, Nauck M, Volzke H, Weidner H, et al
    Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
    J Clin Endocrinol Metab. 2021;106:e288-e299.
    PubMed     Abstract available


    November 2020
  41. FENG SH, Huang YP, Yeh KC, Pan SL, et al
    Osteoporosis and the risk of Parkinson's disease: A nationwide propensity score-matched longitudinal follow-up study.
    J Clin Endocrinol Metab. 2020 Nov 25. pii: 6000490. doi: 10.1210.
    PubMed     Abstract available


  42. BROADWELL A, Chines A, Ebeling PR, Franek E, et al
    Denosumab Safety and Efficacy Among Subjects in the FREEDOM Extension Study With Mild-to-Moderate Chronic Kidney Disease.
    J Clin Endocrinol Metab. 2020 Nov 19. pii: 5992310. doi: 10.1210.
    PubMed     Abstract available


  43. HOFSO D, Hillestad TOW, Halvorsen E, Fatima F, et al
    Bone mineral density and bone turnover after sleeve gastrectomy and gastric bypass, a randomized controlled trial.
    J Clin Endocrinol Metab. 2020 Nov 5. pii: 5956311. doi: 10.1210.
    PubMed     Abstract available


  44. CHARLIER S, Vavanikunnel J, Becker C, Jick SS, et al
    Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study.
    J Clin Endocrinol Metab. 2020 Nov 3. pii: 5952698. doi: 10.1210.
    PubMed     Abstract available


    October 2020
  45. TSOURDI E, Zillikens MC, Meier C, Body JJ, et al
    Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
    J Clin Endocrinol Metab. 2020 Oct 26. pii: 5939974. doi: 10.1210.
    PubMed     Abstract available


  46. DI FILIPPO L, Formenti AM, Doga M, Pedone E, et al
    Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes.
    J Clin Endocrinol Metab. 2020 Oct 21. pii: 5923308. doi: 10.1210.
    PubMed     Abstract available


  47. COHEN A, Shiau S, Nair N, Recker RR, et al
    Effect of Teriparatide on Bone Remodeling and Density in Premenopausal Idiopathic Osteoporosis: A Phase II Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    September 2020
  48. LANGDAHL B
    Treatment of premenopausal women with osteoporosis.
    J Clin Endocrinol Metab. 2020 Sep 22. pii: 5910063. doi: 10.1210.
    PubMed    


  49. KREZ A, Agarwal S, Bucovsky M, McMahon DJ, et al
    Long-term Bone Loss and Deterioration of Microarchitecture After Gastric Bypass in African American and Latina Women.
    J Clin Endocrinol Metab. 2020 Sep 16. pii: 5906394. doi: 10.1210.
    PubMed     Abstract available


  50. VAN SANTEN SS, Olsson DS, Hammarstrand C, Wijnen M, et al
    Body composition and bone mineral density in craniopharyngioma patients: a longitudinal study over 10 years.
    J Clin Endocrinol Metab. 2020 Sep 1. pii: 5900043. doi: 10.1210.
    PubMed     Abstract available


    August 2020
  51. QU Z, Yang F, Hong J, Wang W, et al
    Parathyroid hormone and bone mineral density: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2020 Aug 22. pii: 5896008. doi: 10.1210.
    PubMed     Abstract available


  52. LIU Y, Shen H, Greenbaum J, Liu A, et al
    Gene Expression and RNA Splicing Imputation Identifies Novel Candidate Genes Associated with Osteoporosis.
    J Clin Endocrinol Metab. 2020 Aug 21. pii: 5895512. doi: 10.1210.
    PubMed     Abstract available


  53. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
    ERRATUMERRATUM for "Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    July 2020
  54. RODRIGUEZ AJ, Ernst MT, Nybo M, Prieto-Alhambra D, et al
    Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density.
    J Clin Endocrinol Metab. 2020 Jul 27. pii: 5876920. doi: 10.1210.
    PubMed     Abstract available


  55. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Response to Letter to the Editor from Min Gong et al: (Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis).
    J Clin Endocrinol Metab. 2020 Jul 17. pii: 5873223. doi: 10.1210.
    PubMed    


  56. GONG M, Huang G, Xu C
    Letter to the Editor from Min Gong et al: (Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis).
    J Clin Endocrinol Metab. 2020 Jul 17. pii: 5873220. doi: 10.1210.
    PubMed    


  57. RACHNER TD, Gobel A, Jaschke NP, Hofbauer LC, et al
    Challenges in preventing bone loss induced by aromatase inhibitors.
    J Clin Endocrinol Metab. 2020 Jul 16. pii: 5872610. doi: 10.1210.
    PubMed     Abstract available


  58. COSMAN F, Peterson LR, Towler DA, Mitlak B, et al
    Cardiovascular Safety of Abaloparatide in Postmenopausal Women with Osteoporosis: Analysis from the ACTIVE Phase 3 Trial.
    J Clin Endocrinol Metab. 2020 Jul 13. pii: 5870711. doi: 10.1210.
    PubMed     Abstract available


  59. ALAJLOUNI D, Bliuc D, Tran T, Eisman JA, et al
    Decline in muscle strength and performance predicts fracture risk in elderly women and men.
    J Clin Endocrinol Metab. 2020 Jul 8. pii: 5868761. doi: 10.1210.
    PubMed     Abstract available


    June 2020
  60. KINDLER JM, Kalkwarf HJ, Lappe JM, Gilsanz V, et al
    Pediatric Reference Ranges for Ultradistal Radius Bone Density: Results from the Bone Mineral Density in Childhood Study.
    J Clin Endocrinol Metab. 2020 Jun 19. pii: 5860168. doi: 10.1210.
    PubMed     Abstract available


  61. MAZZIOTTI G, Betella N, Lania AG
    Letter to the Editor: ["Delayed Denosumab Injections and Bone Mineral Density Response: En Electronic Health Record-Based Study"].
    J Clin Endocrinol Metab. 2020 Jun 17. pii: 5859156. doi: 10.1210.
    PubMed    


  62. YAVROPOULOU MP, Anastasilakis AD, Makras P, Papatheodorou A, et al
    Serum profile of microRNAs linked to bone metabolism during sequential treatment for postmenopausal osteoporosis.
    J Clin Endocrinol Metab. 2020 Jun 10. pii: 5855767. doi: 10.1210.
    PubMed     Abstract available


  63. ZHANG L, Peng TL, Wang L, Meng XH, et al
    Network-Based Transcriptome-Wide Expression Study for Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2020 Jun 1. pii: 5850085. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  64. PEPE J, Body JJ, Hadji P, McCloskey E, et al
    Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846185. doi: 10.1210.
    PubMed     Abstract available


  65. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Response to Letter to the Editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
    J Clin Endocrinol Metab. 2020 May 23. pii: 5843473. doi: 10.1210.
    PubMed    


  66. WATTS NB
    Letter to the editor: "Risk for Infections During Treatment with Denosumab for Osteoporosis: a Systematic Review and Meta-analysis".
    J Clin Endocrinol Metab. 2020 May 23. pii: 5843452. doi: 10.1210.
    PubMed    


  67. YEAP BB, Alfonso H, Chubb SAP, Center JR, et al
    U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in Men.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    April 2020
  68. NGUYEN TV
    Toward the era of precision fracture risk assessment.
    J Clin Endocrinol Metab. 2020 Apr 21. pii: 5823064. doi: 10.1210.
    PubMed    


  69. VAN SANTEN SS, Olsson DS, van den Heuvel-Eibrink MM, Wijnen M, et al
    Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  70. NETHANDER M, Pettersson-Kymmer U, Vandenput L, Lorentzon M, et al
    BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  71. GREY A, Horne A, Gamble G, Mihov B, et al
    Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized Trial.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  72. JAIN RK, Weiner MG, Zhao H, Vokes T, et al
    Comorbid conditions and GFR predict non-vertebral fractures in patients with diabetes in an ethnic-specific manner.
    J Clin Endocrinol Metab. 2020 Mar 20. pii: 5810272. doi: 10.1210.
    PubMed     Abstract available


  73. SHOBACK D, Rosen CJ, Black DM, Cheung AM, et al
    Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  74. CIPRIANI C, Bilezikian JP
    Osteoanabolics Versus Antiresorptives: Which First?
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


    February 2020
  75. LI GH, Chau YP, Cheung CL
    Response to Letter to the Editor: Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study.
    J Clin Endocrinol Metab. 2020 Feb 18. pii: 5740110. doi: 10.1210.
    PubMed    


  76. KAWADA T
    Letter to the Editor: "Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study".
    J Clin Endocrinol Metab. 2020 Feb 18. pii: 5740117. doi: 10.1210.
    PubMed    


    January 2020
  77. LUKERT BP
    Which Drug Next? Sequential Therapy for Osteoporosis.
    J Clin Endocrinol Metab. 2020 Jan 10. pii: 5700360. doi: 10.1210.
    PubMed     Abstract available


  78. YANG WP, Chang HH, Li HY, Lai YC, et al
    Iron Overload Associated Endocrine Dysfunction Leading to Lower Bone Mineral Density in Thalassemia Major.
    J Clin Endocrinol Metab. 2020 Jan 7. pii: 5697444. doi: 10.1210.
    PubMed     Abstract available


  79. DIKER-COHEN T, Rosenberg D, Avni T, Shepshelovich D, et al
    Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2020 Jan 3. pii: 5695688. doi: 10.1210.
    PubMed     Abstract available


  80. LYU H, Zhao SS, Yoshida K, Tedeschi SK, et al
    Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study.
    J Clin Endocrinol Metab. 2020 Jan 2. pii: 5693392. doi: 10.1210.
    PubMed     Abstract available



  81. CORRIGENDUM for "Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women".
    J Clin Endocrinol Metab. 2020;105.
    PubMed    


  82. DING L, Hu J, Wang D, Liu Q, et al
    Efficacy and Safety of First- and Second-Line Drugs to Prevent Glucocorticoid-Induced Fractures.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    December 2019
  83. EL-HAJJ FULEIHAN G
    Building Bridges to Address the Osteoporosis Crisis.
    J Clin Endocrinol Metab. 2019 Dec 31. pii: 5691193. doi: 10.1210.
    PubMed    


  84. MA J, Lin X, Chen C, Li S, et al
    Circulating miR-181c-5p and miR-497-5p are potential biomarkers for prognosis and diagnosis of osteoporosis.
    J Clin Endocrinol Metab. 2019 Dec 24. pii: 5686162. doi: 10.1210.
    PubMed     Abstract available


  85. WARD LM, Weber DR, Munns CF, Hogler W, et al
    A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents.
    J Clin Endocrinol Metab. 2019 Dec 22. pii: 5684884. doi: 10.1210.
    PubMed     Abstract available


  86. SHIEH A, Greendale GA, Cauley JA, Karlamangla AS, et al
    The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
    J Clin Endocrinol Metab. 2019 Dec 16. pii: 5678661. doi: 10.1210.
    PubMed     Abstract available


  87. LI M, Yao S, Duan YY, Zhang YJ, et al
    Transcription Factor Enrichment Analysis in Enhancers Identifies EZH2 as A Susceptibility Gene for Osteoporosis.
    J Clin Endocrinol Metab. 2019 Dec 13. pii: 5675148. doi: 10.1210.
    PubMed     Abstract available


  88. MAIMOUN L, Garnero P, Mura T, Nocca D, et al
    Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women.
    J Clin Endocrinol Metab. 2019 Dec 10. pii: 5672712. doi: 10.1210.
    PubMed     Abstract available


    November 2019
  89. CHAU YP, Au PCM, Li GHY, Sing CW, et al
    Serum Metabolome of Coffee Consumption and its Association with Bone Mineral Density: The Hong Kong Osteoporosis Study.
    J Clin Endocrinol Metab. 2019 Nov 21. pii: 5637088. doi: 10.1210.
    PubMed     Abstract available


  90. BLUMENFELD Z, Lavie G
    Menopausal transition bone loss- what are the practical implications.
    J Clin Endocrinol Metab. 2019 Nov 19. pii: 5629158. doi: 10.1210.
    PubMed    


  91. GONZALEZ RODRIGUEZ E, Stuber M, Del Giovane C, Feller M, et al
    Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study.
    J Clin Endocrinol Metab. 2019 Nov 8. pii: 5614779. doi: 10.1210.
    PubMed     Abstract available


  92. HALPER-STROMBERG E, Gallo T, Champakanath A, Taki I, et al
    Bone Mineral Density across the Life-Span in Patients with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Nov 2. pii: 5611085. doi: 10.1210.
    PubMed     Abstract available


  93. LEDER BZ, Mitlak B, Hu MY, Hattersley G, et al
    Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
    J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610884. doi: 10.1210.
    PubMed     Abstract available


  94. RAMCHAND SK, David NL, Leder BZ, Tsai JN, et al
    Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.
    J Clin Endocrinol Metab. 2019 Nov 1. pii: 5610890. doi: 10.1210.
    PubMed     Abstract available


    October 2019
  95. ANAGNOSTIS P, Kenanidis E, Potoupnis M, Tsiridis E, et al
    Letter to the Editor: "Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline."
    J Clin Endocrinol Metab. 2019 Oct 28. pii: 5607923. doi: 10.1210.
    PubMed    


  96. KENDLER D, Chines A, Clark P, Ebeling PR, et al
    Bone Mineral Density After Transitioning From Denosumab to Alendronate.
    J Clin Endocrinol Metab. 2019 Oct 26. pii: 5607536. doi: 10.1210.
    PubMed     Abstract available


  97. LI GH, Robinson-Cohen C, Sahni S, Au PC, et al
    Association of Genetic Variants Related to Serum Calcium Levels with Reduced Bone Mineral Density.
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606940. doi: 10.1210.
    PubMed     Abstract available


  98. LYU H, Zhao SS, Solomon DH
    Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606941. doi: 10.1210.
    PubMed    


  99. GEUSENS P, Marin F, Kendler DL
    Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
    J Clin Endocrinol Metab. 2019 Oct 25. pii: 5606939. doi: 10.1210.
    PubMed    


  100. SUGIYAMA T
    Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602688. doi: 10.1210.
    PubMed    


  101. MURAI IH, Roschel H, Gualano B
    Response to Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
    J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602687. doi: 10.1210.
    PubMed    


  102. MERLOTTI D, Rendina D, Muscariello R, Picchioni T, et al
    PREVENTIVE ROLE OF VITAMIN D SUPPLEMENTATION FOR ACUTE PHASE REACTION AFTER BISPHOSPHONATE INFUSION IN PAGET'S DISEASE.
    J Clin Endocrinol Metab. 2019 Oct 22. pii: 5601913. doi: 10.1210.
    PubMed     Abstract available


  103. CHILOIRO S, Antonella G, Frara S, Bima C, et al
    Effects of Pegvisomant and Pasireotide LAR on vertebral fractures in acromegaly resistant to First-Generation SRLs.
    J Clin Endocrinol Metab. 2019 Oct 15. pii: 5588033. doi: 10.1210.
    PubMed     Abstract available


    September 2019
  104. ZHAO Z, Wang L, Fu Z, Ji L, et al
    The prevalence of osteoporosis tested by quantitative computed tomography in patients with different glucose tolerances.
    J Clin Endocrinol Metab. 2019 Sep 23. pii: 5572675. doi: 10.1210.
    PubMed     Abstract available


    May 2019
  105. BARRIONUEVO P, Kapoor E, Asi N, Alahdab F, et al
    Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
    J Clin Endocrinol Metab. 2019;104:1623-1630.
    PubMed     Abstract available


  106. ALOIA JF, Mikhail M, Fazzari M, Islam S, et al
    Physical Performance and Vitamin D in Elderly Black Women-The PODA Randomized Clinical Trial.
    J Clin Endocrinol Metab. 2019;104:1441-1448.
    PubMed     Abstract available


    March 2019
  107. CHEN SC, Shepherd S, McMillan M, McNeilly J, et al
    Skeletal Fragility & Its Clinical Determinants In Children With Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Mar 8. pii: 5371250. doi: 10.1210/jc.2019-00084.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: